Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SUTRO BIOPHARMA, INC.STRO · Entity 5797 | Pres. Rsrch & Cf. Sctific Ofcr | April 14, 2023 | April 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SUTRO BIOPHARMA, INC.
Report date April 14, 2023 · Filed April 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,368 |
Ending reported balance
After 2023-04-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-04-14 · Exercise / conversion · Acquired 3,750 · Balance 101,664 Row 2 · 2023-04-14 · Tax withholding · Disposed 1,296 · Balance 100,368 F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. |
| Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security · Expires 2025-04-16 | Direct | 7,500 |
Reported balance
After 2023-04-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-04-14 · Exercise / conversion · Disposed 3,750 · Balance 7,500 F2: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3: The RSUs vest as to 1/4th of the total shares annually beginning on April 16, 2022, subject to continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
F2: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F3: The RSUs vest as to 1/4th of the total shares annually beginning on April 16, 2022, subject to continued service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2023 Filed Apr 17, 2023 18:53 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024550 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 3,750 shares Expires 2025-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on April 16, 2022, subject to continued service through each vesting date. Read SEC document |
| April 14, 2023 Filed Apr 17, 2023 18:53 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Tax withholdingCommon Stock | 1,296 | $4.40 | $5,702.40 |
DisclosureSEC source: 0001209191-23-024550 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,368 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| April 14, 2023 Filed Apr 17, 2023 18:53 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024550 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:30 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016751 · doc4.xml · derivative · entry 7 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 12,500 shares Expires 2025-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F6 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:30 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 9,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016751 · doc4.xml · derivative · entry 6 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,250 Underlying: Common Stock · 9,750 shares Expires 2026-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F5 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:30 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | GrantRestricted Stock Unit (RSU) · Derivative | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016751 · doc4.xml · derivative · entry 5 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-03-01 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F4 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:30 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | GrantStock Option (right to buy Common Stock) · Derivative | 50,000 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001209191-23-016751 · doc4.xml · derivative · entry 4 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-02-28 F3 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on April 1, 2023, with 100% of the total shares vested and exercisable on March 1, 2027, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:30 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Tax withholdingCommon Stock | 7,717 | $5.79 | $44,681.43 |
DisclosureSEC source: 0001209191-23-016751 · doc4.xml · nonDerivative · entry 3 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,914 F2 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:30 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-016751 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:30 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 9,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-016751 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 17:27 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-005759 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Common Stock · 5,250 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 17:27 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Tax withholdingCommon Stock | 2,140 | $7.50 | $16,050.00 |
DisclosureSEC source: 0001209191-23-005759 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,381 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 17:27 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-005759 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 19:19 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-024540 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 3,750 shares Expires 2025-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on April 16, 2022, subject to continued service through each vesting date. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 19:19 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Tax withholdingCommon Stock | 1,296 | $7.26 | $9,408.96 |
DisclosureSEC source: 0001209191-22-024540 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,271 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 19:19 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-024540 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2022 Filed Mar 7, 2022 19:22 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016854 · doc4.xml · derivative · entry 5 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 12,500 shares Expires 2025-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F5 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. Read SEC document |
| March 05, 2022 Filed Mar 7, 2022 19:22 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Tax withholdingCommon Stock | 4,278 | $8.17 | $34,951.26 |
DisclosureSEC source: 0001209191-22-016854 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,817 F2 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| March 05, 2022 Filed Mar 7, 2022 19:22 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-016854 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 19:22 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | GrantRestricted Stock Unit (RSU) · Derivative | 39,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016854 · doc4.xml · derivative · entry 4 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,000 Underlying: Common Stock · 39,000 shares Expires 2026-03-04 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F4 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 19:22 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | GrantStock Option (right to buy Common Stock) · Derivative | 52,000 | $0.00 Strike: $8.17 | $0.00 |
DisclosureSEC source: 0001209191-22-016854 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2032-03-03 F3 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on April 4, 2022, with 100% of the total shares vested and exercisable on March 4, 2026, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| January 29, 2022 Filed Feb 1, 2022 20:34 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006125 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 5,250 shares Expires 2025-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2022 Filed Feb 1, 2022 20:34 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Tax withholdingCommon Stock | 2,151 | $10.39 | $22,348.89 |
DisclosureSEC source: 0001209191-22-006125 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,595 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 29, 2022 Filed Feb 1, 2022 20:34 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006125 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2021 Filed Sep 28, 2021 18:55 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057978 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,019 shares Expires 2021-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 24, 2021 Filed Sep 28, 2021 18:55 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Tax withholdingCommon Stock | 3,810 | $19.23 | $73,266.30 |
DisclosureSEC source: 0001209191-21-057978 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,496 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| September 24, 2021 Filed Sep 28, 2021 18:55 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 11,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057978 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 17:38 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | GrantRestricted Stock Unit (RSU) · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027600 · doc4.xml · derivative · entry 2 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2025-04-16 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on April 16, 2022, subject to continued service through each vesting date. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 17:38 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | GrantStock Option (right to buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $20.01 | $0.00 |
DisclosureSEC source: 0001209191-21-027600 · doc4.xml · derivative · entry 1 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-04-15 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on May 16, 2021, with 100% of the total shares vested and exercisable on April 16, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:19 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | GrantRestricted Stock Unit (RSU) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018620 · doc4.xml · derivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2025-03-05 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:19 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | GrantStock Option (right to buy Common Stock) · Derivative | 60,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018620 · doc4.xml · derivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-03-04 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:55 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006557 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 5,250 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:55 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Tax withholdingCommon Stock | 2,080 | $22.15 | $46,072.00 |
DisclosureSEC source: 0001209191-21-006557 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,287 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:55 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006557 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:04 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,393 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-21-005712 · doc4.xml · derivative · entry 4 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4 Underlying: Common Stock · 2,393 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:04 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | SaleCommon Stock | 165 | $26.10 | $4,306.15 |
DisclosureSEC source: 0001209191-21-005712 · doc4.xml · nonDerivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,117 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $26.10 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:04 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | SaleCommon Stock | 2,228 | $25.68 | $57,221.72 |
DisclosureSEC source: 0001209191-21-005712 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,282 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.05 to $25.91 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:04 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 2,393 | $4.36 | $10,433.48 |
DisclosureSEC source: 0001209191-21-005712 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 14, 2021 Filed Jan 15, 2021 18:10 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 19,405 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-21-003875 · doc4.xml · derivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,405 shares Expires 2022-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 14, 2021 Filed Jan 15, 2021 18:10 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 19,405 | $4.36 | $84,605.80 |
DisclosureSEC source: 0001209191-21-003875 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 17:00 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,393 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-20-065371 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,397 Underlying: Common Stock · 2,393 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 17:00 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | SaleCommon Stock | 2,393 | $22.37 | $53,530.21 |
DisclosureSEC source: 0001209191-20-065371 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,712 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.89 to $22.635 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 17:00 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 2,393 | $4.36 | $10,433.48 |
DisclosureSEC source: 0001209191-20-065371 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 17:14 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,393 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-20-060756 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,790 Underlying: Common Stock · 2,393 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 17:14 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | SaleCommon Stock | 2,393 | $17.01 | $40,713.07 |
DisclosureSEC source: 0001209191-20-060756 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,712 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.505 to $17.36 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 17:14 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 2,393 | $4.36 | $10,433.48 |
DisclosureSEC source: 0001209191-20-060756 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 17:08 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 16,751 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-20-057311 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,183 Underlying: Common Stock · 16,751 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 17:08 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | SaleCommon Stock | 16,751 | $15.00 | $251,265.00 |
DisclosureSEC source: 0001209191-20-057311 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,712 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 17:08 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionCommon Stock | 16,751 | $4.36 | $73,034.36 |
DisclosureSEC source: 0001209191-20-057311 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 16:54 UTC | SUTRO BIOPHARMA, INC. STRO · Entity 5797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,182 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-20-054025 · doc4.xml · derivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,934 Underlying: Common Stock · 9,182 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.